Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
EPS (Diluted)
Glenmark Life Sciences Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
EPS (Diluted)
₹38
|
CAGR 3-Years
10%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
EPS (Diluted)
₹334
|
CAGR 3-Years
42%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
EPS (Diluted)
₹51
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
11%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
EPS (Diluted)
₹37
|
CAGR 3-Years
55%
|
CAGR 5-Years
21%
|
CAGR 10-Years
11%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
EPS (Diluted)
₹29
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
EPS (Diluted)
₹44
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
See Also
What is Glenmark Life Sciences Ltd's EPS (Diluted)?
EPS (Diluted)
38.4
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's EPS (Diluted) amounts to 38.4 INR.
What is Glenmark Life Sciences Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
19%
Over the last year, the EPS (Diluted) growth was 1%. The average annual EPS (Diluted) growth rates for Glenmark Life Sciences Ltd have been 10% over the past three years , 19% over the past five years .